Trial intelligence / Profile preview

PIGREC: PK Models for Immunosuppressants in Heart Transplant

NCT00812786Phase 4Completed

Sponsor
CHU de Limoges
Start
Jul 2007
Primary completion
May 2011
Modality
Peptides, RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine, tacrolimus, mycophenolate mofetil, everolimus in heart transplant rejection, sponsored by CHU de Limoges. Started Jul 2007; status: completed.

02

Drugs

cyclosporinetacrolimusmycophenolate mofetileverolimus
03

Conditions

heart transplant rejection

Beyond the preview

Go deeper on NCT00812786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00812786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call